Genetic vaccination approaches against malaria based on the circumsporozoite protein

Wiener Klinische Wochenschrift, Supplement

Volumn 118, Issue 3, 2006, Pages 9-17

  Scheiblhofer, Sandra ^a   Weiss, Richard ^a   Thalhamer, Josef ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Circumsporozoite protein; DNA vaccine; Gene gun; Genetic immunization; Malaria

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; MALARIA VACCINE;

CELLULAR IMMUNITY; CLINICAL TRIAL; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; GENE GUN; GENETIC IMMUNIZATION; HUMAN; HUMORAL IMMUNITY; MALARIA; NONHUMAN; REVIEW;

ANIMALS; ANTIBODIES, PROTOZOAN; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; VACCINES, COMBINED; VACCINES, DNA;

EID: 33846397189     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0676-0     Document Type: Review

References (58)

1. Good MF (2001) Towards a blood-stage vaccine for malaria: are e following all the leads? Nat Rev Immunol 1: 117-125
2. Hisaeda H, Yasutomo K (2002) Development of malaria vaccines that block transmission of parasites by mosquito vectors. J Med Invest 49: 118-123
3. Nussenzweig V, Nussenzweig RS (1989) Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 45: 283-334
4. Hoffman SL, Doolan DL (2000) Malaria vaccines-targeting infected hepatocytes. Nat Med 6: 1218-1219
5. Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS (1999) Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Parassitologia 41: 397-402
6. Doolan DL, Hoffman SL (2001) DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int J Parasitol 31: 753-762
7. Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al (2005) Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23: 2243-2250
8. Kumar S, Epstein JE, Richie TL, Nkrumah FK, Soisson L, Carucci DJ, et al (2002) A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol 18: 129-135
9. Gurunathan S, Klinman DM, Seder RA (2000) DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18: 927-974
10. Sedegah M, Hedstrom R, Hobart P, Hoffman SL (1994) Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 91: 9866-9870
11. Hoffman SL, Sedegah M, Hedstrom RC (1994) Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 12: 1529-1533
12. Mor G, Klinman DM, Shapiro S, Hagiwara E, Sedegah M, Norman JA, et al (1995) Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 155: 2039-2046
13. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL (1996) Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med 183: 1739-1746
14. Doolan DL, Hedstrom RC, Rogers WO, Charoenvit Y, Rogers M, de la Vega P, et al (1996) Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J Biol Chem 271: 17861-17868
15. Hanke T, Schneider J, Gilbert SC, Hill AV, McMichael A (1998) DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine 16: 426-435
16. Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, et al (1997) Malaria DNA vaccines in Aotus monkeys. Vaccine 15: 913-915
17. Rathore D, Kumar S, Lanar DE, McCutchan TF (2001) Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice. Mol Biochem Parasitol 118: 75-82
18. Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, et al (1998) A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 161: 2325-2332
19. Mor G, Yamshchikov G, Sedegah M, Takeno M, Wang R, Houghten RA, et al (1996) Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest 98: 2700-2705
20. Ishii KJ, Weiss WR, Klinman DM (1999) Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor. Vaccine 18: 703-710
21. Sedegah M, Belmonte M, Epstein JE, Siegrist CA, Weiss WR, Jones TR, et al (2003) Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J Immunol 171: 3148-3153
22. Sedegah M, Weiss W, Sacci JB Jr, Charoenvit Y, Hedstrom R, Gowda K, et al (2000) Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. J Immunol 164: 5905-5912
23. Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, et al (2002) Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations. Infect Immun 70: 3493-3499
24. Sedegah M, Charoenvit Y, Aguiar J, Sacci J, Hedstrom R, Kumar S, et al (2004) Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun 5: 553-561
25. Yoshida S, Kashiwamura SI, Hosoya Y, Luo E, Matsuoka H, Ishii A, et al (2000) Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem Biophys Res Commun 271: 107-115
26. Aguiar JC, Hedstrom RC, Rogers WO, Charoenvit Y, Sacci JB Jr, Lanar DE, et al (2001) Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20: 275-280
27. Rogers WO, Baird JK, Kumar A, Tine JA, Weiss W, Aguiar JC, et al (2001) Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect Immun 69: 5565-5572
28. Wang R, Epstein J, Baraceros FM, Gorak EJ, Charoenvit Y, Carucci DJ, et al (2001) Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA 98: 10817-10822
29. Epstein JE, Gorak EJ, Charoenvit Y, Wang R, Freydberg N, Osinowo O, et al (2002) Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/ intradermal routes. Hum Gene Ther 13: 1551-1560
30. Epstein JE, Charoenvit Y, Kester KE, Wang R, Newcomer R, Fitzpatrick S, et al (2004) Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. Vaccine 22: 1592-1603
31. Wang R, Epstein J, Charoenvit Y, Baraceros FM, Rahardjo N, Gay T, et al (2004) Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. J Immunol 172: 5561-5569
32. Chen D, Payne LG (2002) Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res 12: 97-104
33. Leitner WW, Seguin MC, Ballou WR, Seitz JP, Schultz AM, Sheehy MJ, et al (1997) Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol 159: 6112-6119
34. Weiss R, Leitner WW, Scheiblhofer S, Chen D, Bernhaupt A, Mostbock S, et al (2000) Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect Immun 68: 5914-5919
35. Scheiblhofer S, Chen D, Weiss R, Khan F, Mostbock S, Fegeding K, et al (2001) Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection. Eur J Immunol 31: 692-698
36. Bergmann-Leitner ES, Scheiblhofer S, Weiss R, Duncan EH, Leitner WW, Chen D, et al (2005) C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int Immunol 17: 245-255
37. Wang J, Murakami T, Yoshida S, Matsuoka H, Ishii A, Tanaka T, et al (2003) Predominant cell-mediated immunity in the oral mucosa: gene gun-based vaccination against infectious diseases. J Dermatol Sci 31: 203-210
38. Walsh DS, Gettayacamin M, Leitner WW, Lyon JA, Stewart VA, Marit G, et al (2006) Heterologous primeboost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A. Vaccine 24: 4167-4178
39. Smooker PM, Setiady YY, Rainczuk A, Spithill TW (2000) Expression library immunization protects mice against a challenge with virulent rodent malaria. Vaccine 18: 2533-2540
40. Sedegah M, Rogers WO, Belmonte A, Belmonte M, Banania G, Patterson N, et al (2006) Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines. Vaccine 24: 1921-1927
41. Rottinghaus ST, Poland GA, Jacobson RM, Barr LJ, Roy MJ (2003) Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 21: 4604-4608
42. Hedstrom RC, Doolan DL, Wang R, Kumar A, Sacci JB Jr, Gardner MJ, et al (1998) In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int J Mol Med 2: 29-38
43. Wang R, Doolan DL, Charoenvit Y, Hedstrom RC, Gardner MJ, Hobart P, et al (1998) Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in non-human primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun 66: 4193-4202
44. Grifantini R, Finco O, Bartolini E, Draghi M, Del Giudice G, Kocken C, et al (1998) Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid. Eur J Immunol 28: 1225-1232
45. Rogers WO, Gowda K, Hoffman SL (1999) Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens. Vaccine 17: 3136-3144
46. Sedegah M, Charoenvit Y, Minh L, Belmonte M, Majam VF, Abot S, et al (2004) Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther 11: 448-456
47. Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, Tine JA, et al (1998) Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci USA 95: 7648-7653
48. Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, et al (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4: 397-402
49. Bhardwaj D, Kushwaha A, Puri SK, Herrera A, Singh N, Chauhan VS (2003) DNA prime-protein boost immunization in monkeys: efficacy of a novel construct containing functional domains of Plasmodium cynomolgi CS and TRAP. FEMS Immunol Med Microbiol 39: 241-250
50. Hill AV (2006) Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 6: 21-32
51. Parker SE, Borellini F, Wenk ML, Hobart P, Hoffman SL, Hedstrom R, et al (1999) Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Hum Gene Ther 10: 741-758
52. Martin T, Parker SE, Hedstrom R, Le T, Hoffman SL, Norman J, et al (1999) Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Hum Gene Ther 10: 759-768
53. Parker SE, Monteith D, Horton H, Hof R, Hernandez P, Vilalta A, et al (2001) Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther 8: 1011-1023
54. Manam S, Ledwith BJ, Barnum AB, Troilo PJ, Pauley CJ, Harper LB, et al (2000) Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43: 273-281
55. Kang KK, Choi SM, Choi JH, Lee DS, Kim CY, Ahn BO, et al (2003) Safety evaluation of GX-12, a new HIV therapeutic vaccine: investigation of integration into the host genome and expression in the reproductive organs. Intervirology 46: 270-276
56. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, et al (1998) Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282: 476-480
57. Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M, Epstein JE, et al (2000) Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18: 1893-1901
58. Grim KC, McCutchan T, Li J, Sullivan M, Graczyk TK, McConkey G, et al (2004) Preliminary results of an anticircumsporozoite DNA vaccine trial for protection against avian malaria in captive African black-footed penguins (Spheniscus demersus). J Zoo Wildl Med 35: 154-161